COVID-19 has put supply chain risk management practices under the microscope. Coming on the heels of many other, more localized supply issues in the last decade, it has brought about a near-global assessment that supply chains need to be more tightly controlled and redundant – and less dependent on external, at-risk suppliers. In a sense,[…]
LGM Helps Pharma Manage Supply Chain Risks with Added Services Through Nexgen Acquisition
blog, Bulk Active Ingredient, Drug Research & Development API, LGM Pharma, Supply Chain Tags: analytical methods developmentCDMODrug Developmentdrug manufacturingformulations developmentLGM PharmaNexgenpackagingsemi-solidsolid dosesupply chain Nov 02, 2020
